Jan 5, 2012 | MLive.com
Perrigo approved to market generic Clarinex; hopes to market generic version of Mucinex
Store-brand products maker Perrigo Co. says it has received final approval to market a generic version of seasonal allergy product Clarinex.
Perrigo announces summertime availability of desloratadine in either Rx or OTC
Perrigo last week announced that it has received final Food and Drug Administration approval for its generic prescription allergy remedy desloratadine , the generic equivalent to Schering-Plough's Clarinex.
Perrigo Announces FDA Final Approval For Desloratadine
Main Category: Allergy Also Included In: Ear, Nose and Throat ; Regulatory Affairs / Drug Approvals ; Pharma Industry / Biotech Industry Article Date: 29 Dec 2011 - 1:00 PST Perrigo Company announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Desloratadine tablets .
Perrigo Announces FDA Final Approval for Desloratadine
Under the terms of the settlement, Perrigo can commercially launch its generic Desloratadine product on , or earlier in certain circumstances.
Also on Topix